Dr. Pradeep Natarajan to Receive 2026 Population Research Prize
The American Heart Association honors Dr. Pradeep Natarajan for his groundbreaking research in cardiovascular genetics.
Dr. Natarajan is recognized for his contributions to understanding cardiovascular disease through genetics.
He will receive the award at the AHA's Scientific Sessions in Chicago on November 8, 2026.
Natarajan has published over 330 peer-reviewed articles and led significant NIH-funded research.
Dr. Pradeep Natarajan, a prominent cardiovascular geneticist affiliated with Massachusetts General Hospital and Harvard Medical School, has been awarded the 2026 Population Research Prize by the American Heart Association (AHA). This prestigious recognition is set to be presented during the AHA's Scientific Sessions in Chicago on November 8, 2026, which will take place from November 6 to 9.
Natarajan serves as the Director of Preventive Cardiology at Massachusetts General Hospital, where he focuses on the genetic factors contributing to cardiovascular diseases. His research employs large population studies and genetic analysis to enhance understanding and prevention strategies for cardiovascular conditions. His profile at Mass General highlights his expertise in the genetic drivers of atherosclerosis, a key factor in heart disease.
The AHA commended Natarajan for his innovative work in utilizing genetic variation and biomedical data to improve cardiovascular disease prevention. His research has significantly advanced the development of polygenic risk scores, which help identify individuals at higher risk for cardiovascular issues. Furthermore, he has been instrumental in studying lipid disorders and coronary artery disease, contributing to a deeper understanding of these conditions.
Natarajan's educational background includes a bachelor's degree from the University of California, Berkeley, and a medical degree from the University of California, San Francisco. He also holds a Master of Medical Sciences in biomedical informatics from Harvard Medical School. His extensive research career includes significant contributions to genetic epidemiology and genomic studies, with a focus on translating genetic findings into practical preventive measures for cardiovascular health.
Looking ahead, Natarajan's ongoing work is expected to further influence the field of cardiovascular genetics. His involvement with the AHA spans over a decade, and he has held leadership roles within its committees. As he prepares to receive the Population Research Prize, his future endeavors will likely continue to shape the landscape of cardiovascular research and precision medicine.
